Molecular logic underlying chromosomal translocations, random or non-random?

Adv Cancer Res. 2012:113:241-79. doi: 10.1016/B978-0-12-394280-7.00015-4.

Abstract

Chromosomal translocations serve as essential diagnostic markers and therapeutic targets for leukemia, lymphoma, and many types of solid tumors. Understanding the mechanisms of chromosomal translocation generation has remained a central biological question for decades. Rather than representing a random event, recent studies indicate that chromosomal translocation is a non-random event in a spatially regulated, site-specific, and signal-driven manner, reflecting actions involved in transcriptional activation, epigenetic regulation, three-dimensional nuclear architecture, and DNA damage-repair. In this review, we will focus on the progression toward understanding the molecular logic underlying chromosomal translocation events and implications of new strategies for preventing chromosomal translocations.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Biomarkers, Tumor / genetics
  • Chromosome Aberrations
  • DNA Breaks, Double-Stranded*
  • DNA Repair
  • DNA Transposable Elements / genetics
  • Genomic Instability / genetics*
  • Humans
  • Neoplasms / diagnosis
  • Neoplasms / genetics*
  • Neoplasms / pathology
  • Translocation, Genetic*

Substances

  • Biomarkers, Tumor
  • DNA Transposable Elements